Ignite Creation Date:
2025-12-24 @ 10:09 PM
Ignite Modification Date:
2025-12-25 @ 7:44 PM
Study NCT ID:
NCT05066035
Status:
COMPLETED
Last Update Posted:
2021-10-04
First Post:
2021-09-09
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Residual Paralysis and Reversal With Routine Neostigmine Versus Half-dose Sugammadex and Routine Neostigmine
Sponsor:
Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-05-01
Start Date Type:
ACTUAL
Primary Completion Date:
2016-10-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-12-30
Completion Date Type:
ACTUAL
First Submit Date:
2021-09-09
First Submit QC Date:
None
Study First Post Date:
2021-10-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-09-23
Last Update Post Date:
2021-10-04
Last Update Post Date Type:
ACTUAL